Document is current
Any future updates will be listed below
-
Authors
Ponnusamy, Kanagaraju https://orcid.org/0000-0002-6618-9104
Karaxhuku, Klesti
Jiang, Yuchao https://orcid.org/0000-0002-4465-0457
Randzavola, Lyra
Ren, Hongwei
Leontari, Ilia
Lye, Bryan https://orcid.org/0000-0001-5058-7469
Zaidi, Mehmood
Bartlett, Edward J.
Tate, Edward W. https://orcid.org/0000-0003-2213-5814
Pardalis, Vasileios
Leonardos, Dimitrios
Nadafi, Reza
Sarkar, Irene
Reijmers, Rogier M.
Bua, Marco
Atta, Maria
Katsarou, Alexia
Roberts, Irene AG
Chaidos, Aristeidis https://orcid.org/0000-0003-1453-8576
Karadimitris, Anastasios https://orcid.org/0000-0002-9566-9780
- License Information
-
More Information
Article History
Received: 7 November 2025
Accepted: 3 August 2026
First Online: 14 August 2026
Ethics
Competing interests: A.K. and K.P. report holding options/shares in Arovella Therapeutics Ltd. The rest of the authors declare no competing interests.
